$306.20
7.202.41%
Last update: Nov 6, 7:56 PM
Ligand Pharmaceuticals Inc (LGND) Stock Price, Quote, News & History
LGNDNASDAQ
Ligand to acquire XOMA Royalty for $739 million, raising 2026 outlook as analysts maintain Buy ratings and higher price targets.
You can purchase shares of Ligand Pharmaceuticals (NASDAQ:LGND) through any online brokerage.
Other companies in Ligand Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Ligand Pharmaceuticals has a consensus price target of $302.92.
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $308 last updated November 6, 2026 at 7:56 PM EST.
There are no upcoming dividends for Ligand Pharmaceuticals.
Ligand Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Ligand Pharmaceuticals.
Ligand Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies....
